- Home»
- The Billing Beat Newsletter»
- PIK3CA Gene Tests Coding and Billing Guidelines A53558 A/B MAC Article was Revised
PIK3CA Gene Tests Coding and Billing Guidelines A53558 A/B MAC Article was Revised
July 8, 2019PIK3CA was previously not covered. The FDA approved a new drug for breast cancer that requires PIK3CA testing. This change is effective 5/24/19.
Source: https://www.cms.gov/medicare-coverage-database/details/article-details.aspx